ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CHRISTOPHER RICKMAN MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,564Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 122

$921K Total Retail Price of All Prescriptions

Rank: 1 out of 122

321 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

10% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 8,405 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 532 425 1 1
OMEPRAZOLE 484 397 2 3
LISINOPRIL 459 364 3 2
LEVOTHYROXINE SODIUM 387 334 4 4
CITALOPRAM HBR 305 255 5 15
FUROSEMIDE 305 272 5 5
METOPROLOL SUCCINATE 298 276 7 11
AMLODIPINE BESYLATE 276 247 8 7
HYDROCHLOROTHIAZIDE 215 177 9 6
ATENOLOL 204 140 10 10
METFORMIN HCL 203 161 11 14
METOPROLOL TARTRATE 187 187 12 8
WARFARIN SODIUM 165 137 13 9
POTASSIUM CHLORIDE 138 138 14 22
HYDROCODONE-ACETAMINOPHEN 125 108 S3 15 16
TAMSULOSIN HCL 124 110 16 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 101 17 49
LOSARTAN POTASSIUM 114 94 18 17
ATORVASTATIN CALCIUM 109 81 19 13
CRESTOR 108 72 20 37
DONEPEZIL HCL 108 108 20 25
DIOVAN 107 82 22 40
TRAZODONE HCL 101 93 23 21
SPIRIVA 101 77 23 29
ALLOPURINOL 100 92 25 33
PROAIR HFA 96 60 26 31
NAMENDA 95 92 27 65
RANITIDINE HCL 94 71 28 39
CARVEDILOL 92 62 29 56
PRAVASTATIN SODIUM 88 84 30 27
SPIRONOLACTONE 82 60 31 63
ADVAIR DISKUS 79 70 32 34
AMITRIPTYLINE HCL 78 78 R 33 72
PREDNISONE 75 45 34 24
LOSARTAN-HYDROCHLOROTHIAZIDE 70 58 35 55
FINASTERIDE 69 57 36 76
SERTRALINE HCL 69 51 36 18
FLUTICASONE PROPIONATE 68 42 38 49
NEXIUM 66 40 39 32
GLIPIZIDE XL 63 54 40 106
POLYETHYLENE GLYCOL 3350 62 62 41 75
LANTUS 61 28 42 36
FLOVENT HFA 60 34 43 101
GABAPENTIN 59 51 44 12
PANTOPRAZOLE SODIUM 56 44 45 23
ALENDRONATE SODIUM 56 47 45 35
ROPINIROLE HCL 55 39 47 129
DOXAZOSIN MESYLATE 55 55 47 133
ISOSORBIDE MONONITRATE ER 54 50 49 44
DILTIAZEM ER 53 51 50 132
DIGOXIN 53 52 50 74
VENLAFAXINE HCL ER 53 53 50 54
GEMFIBROZIL 52 40 53 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.